Common Contracts
3 similar Asset Purchase Agreement contracts by Retrophin, Inc., Rhythm Pharmaceuticals, Inc., Spark Therapeutics, Inc.
ASSET PURCHASE AGREEMENT BY AND BETWEEN Alexion Pharmaceuticals, Inc. AND Rhythm Pharmaceuticals, Inc. January 5, 2021 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • January 5th, 2021 • Rhythm Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 5, 2021 (the “Effective Date”), by and between Alexion Pharmaceuticals, Inc., a corporation organized under the laws of the State of Delaware (“Buyer”), and Rhythm Pharmaceuticals, Inc., a corporation organized under the laws of Delaware (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
ASSET PURCHASE AGREEMENT BY AND BETWEEN JAZZ PHARMACEUTICALS IRELAND LIMITED AND SPARK THERAPEUTICS, INC.Asset Purchase Agreement • August 8th, 2018 • Spark Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of April 30, 2018 (the “Effective Date”), by and between JAZZ PHARMACEUTICALS IRELAND LIMITED (“Buyer”) and SPARK THERAPEUTICS, INC. (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
ASSET PURCHASE AGREEMENT BY AND BETWEEN SANOFI AND RETROPHIN, INC. May 22, 2015Asset Purchase Agreement • May 27th, 2015 • Retrophin, Inc. • Pharmaceutical preparations • New York
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of May 22, 2015 (the “Effective Date”), by and between SANOFI (“Buyer”) and RETROPHIN, INC. (“Seller”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
